320 related articles for article (PubMed ID: 27941760)
1. Precise small-molecule recognition of a toxic CUG RNA repeat expansion.
Rzuczek SG; Colgan LA; Nakai Y; Cameron MD; Furling D; Yasuda R; Disney MD
Nat Chem Biol; 2017 Feb; 13(2):188-193. PubMed ID: 27941760
[TBL] [Abstract][Full Text] [Related]
2. Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.
Nguyen L; Luu LM; Peng S; Serrano JF; Chan HY; Zimmerman SC
J Am Chem Soc; 2015 Nov; 137(44):14180-9. PubMed ID: 26473464
[TBL] [Abstract][Full Text] [Related]
3. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.
Reddy K; Jenquin JR; McConnell OL; Cleary JD; Richardson JI; Pinto BS; Haerle MC; Delgado E; Planco L; Nakamori M; Wang ET; Berglund JA
Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20991-21000. PubMed ID: 31570586
[TBL] [Abstract][Full Text] [Related]
4. Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model.
Angelbello AJ; Rzuczek SG; Mckee KK; Chen JL; Olafson H; Cameron MD; Moss WN; Wang ET; Disney MD
Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7799-7804. PubMed ID: 30926669
[TBL] [Abstract][Full Text] [Related]
5. A Small Molecule that Binds an RNA Repeat Expansion Stimulates Its Decay via the Exosome Complex.
Angelbello AJ; Benhamou RI; Rzuczek SG; Choudhary S; Tang Z; Chen JL; Roy M; Wang KW; Yildirim I; Jun AS; Thornton CA; Disney MD
Cell Chem Biol; 2021 Jan; 28(1):34-45.e6. PubMed ID: 33157036
[TBL] [Abstract][Full Text] [Related]
6. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
[TBL] [Abstract][Full Text] [Related]
7. Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive.
Childs-Disney JL; Hoskins J; Rzuczek SG; Thornton CA; Disney MD
ACS Chem Biol; 2012 May; 7(5):856-62. PubMed ID: 22332923
[TBL] [Abstract][Full Text] [Related]
8. Development of pharmacophore models for small molecules targeting RNA: Application to the RNA repeat expansion in myotonic dystrophy type 1.
Angelbello AJ; González ÀL; Rzuczek SG; Disney MD
Bioorg Med Chem Lett; 2016 Dec; 26(23):5792-5796. PubMed ID: 27839685
[TBL] [Abstract][Full Text] [Related]
9. Macrocyclization of a Ligand Targeting a Toxic RNA Dramatically Improves Potency.
Benhamou RI; Vezina-Dawod S; Choudhary S; Won Wang K; Meyer SM; Yildirim I; Disney MD
Chembiochem; 2020 Nov; 21(22):3229-3233. PubMed ID: 32649032
[TBL] [Abstract][Full Text] [Related]
10. A novel CUG(exp)·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1.
Jahromi AH; Nguyen L; Fu Y; Miller KA; Baranger AM; Zimmerman SC
ACS Chem Biol; 2013 May; 8(5):1037-43. PubMed ID: 23480597
[TBL] [Abstract][Full Text] [Related]
11. Precise Targeted Cleavage of a r(CUG) Repeat Expansion in Cells by Using a Small-Molecule-Deglycobleomycin Conjugate.
Angelbello AJ; DeFeo ME; Glinkerman CM; Boger DL; Disney MD
ACS Chem Biol; 2020 Apr; 15(4):849-855. PubMed ID: 32186845
[TBL] [Abstract][Full Text] [Related]
12. Small molecule alteration of RNA sequence in cells and animals.
Guan L; Luo Y; Ja WW; Disney MD
Bioorg Med Chem Lett; 2018 Sep; 28(16):2794-2796. PubMed ID: 29079470
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the Linker Domain in a Dimeric Compound that Degrades an r(CUG) Repeat Expansion in Cells.
Benhamou RI; Abe M; Choudhary S; Meyer SM; Angelbello AJ; Disney MD
J Med Chem; 2020 Jul; 63(14):7827-7839. PubMed ID: 32657583
[TBL] [Abstract][Full Text] [Related]
14. Study of an RNA-Focused DNA-Encoded Library Informs Design of a Degrader of a r(CUG) Repeat Expansion.
Gibaut QMR; Akahori Y; Bush JA; Taghavi A; Tanaka T; Aikawa H; Ryan LS; Paegel BM; Disney MD
J Am Chem Soc; 2022 Dec; 144(48):21972-21979. PubMed ID: 36399603
[TBL] [Abstract][Full Text] [Related]
15. A Ligand That Targets CUG Trinucleotide Repeats.
Li J; Matsumoto J; Bai LP; Murata A; Dohno C; Nakatani K
Chemistry; 2016 Oct; 22(42):14881-14889. PubMed ID: 27573860
[TBL] [Abstract][Full Text] [Related]
16. Expanded DNA and RNA Trinucleotide Repeats in Myotonic Dystrophy Type 1 Select Their Own Multitarget, Sequence-Selective Inhibitors.
Hagler LD; Luu LM; Tonelli M; Lee J; Hayes SM; Bonson SE; Vergara JI; Butcher SE; Zimmerman SC
Biochemistry; 2020 Sep; 59(37):3463-3472. PubMed ID: 32856901
[TBL] [Abstract][Full Text] [Related]
17. A Novel Minor Groove Binder as a Potential Therapeutic Agent for Myotonic Dystrophy Type 1.
Li K; Krueger SB; Zimmerman SC
ChemMedChem; 2021 Sep; 16(17):2638-2644. PubMed ID: 34114350
[TBL] [Abstract][Full Text] [Related]
18. Comparison of small molecules and oligonucleotides that target a toxic, non-coding RNA.
Costales MG; Rzuczek SG; Disney MD
Bioorg Med Chem Lett; 2016 Jun; 26(11):2605-9. PubMed ID: 27117425
[TBL] [Abstract][Full Text] [Related]
19. Features of modularly assembled compounds that impart bioactivity against an RNA target.
Rzuczek SG; Gao Y; Tang ZZ; Thornton CA; Kodadek T; Disney MD
ACS Chem Biol; 2013 Oct; 8(10):2312-21. PubMed ID: 24032410
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Non-ATG Translational Events in Cells via Covalent Small Molecules Targeting RNA.
Yang WY; Wilson HD; Velagapudi SP; Disney MD
J Am Chem Soc; 2015 Apr; 137(16):5336-45. PubMed ID: 25825793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
